Skip to main content
Fig. 6 | Journal for ImmunoTherapy of Cancer

Fig. 6

From: Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition

Fig. 6

Panel a and b shows that overweight/ Class 1 obese males had the longest overall survival (OS) among patients treated with monotherapy (a) and combination (b). Panel c and d shows that overweight/Class 1 obese patients with serum creatinine > = 0.9 mg/dL had the longest OS among patients treated with monotherapy (c) and combination (d)

Back to article page